Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaii Tech Times.
Press releases published on May 28, 2025
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
GlobeNewswire
·
May 28, 2025
NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
CareCloud Announces Results from Annual Shareholders’ Meeting
GlobeNewswire
·
May 28, 2025
Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company’s Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), …
New Episode Now Streaming on Alpha Liquid Podcast, How to Access Powerful AI Agent Tools With Eliza Systems
GlobeNewswire
·
May 28, 2025
Miami, FL, May 28, 2025 (GLOBE NEWSWIRE) -- The latest episode of the Alpha Liquid Podcast, hosted by Matthew Mousa features a thought-provoking conversation with Logan Golema, one of the leading minds behind Eliza Systems, the world’s most trending open- …
4DMT to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
EMERYVILLE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
genXtraits Inc. expands collaboration with The New Zealand Institute for Plant & Food Research Limited to increase vitamin C in crops, including corn and soybean
GlobeNewswire
·
May 28, 2025
ALAMEDA, Calif. , May 28, 2025 (GLOBE NEWSWIRE) -- genXtraits Inc. (genXtraits) today announced that it has expanded its license and collaboration agreement with The New Zealand Institute for Plant and Food Research Limited (Plant …
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present during the …
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will present at the Jefferies Healthcare …
Roadzen to Participate in Fireside Chat at the Maxim Group’s “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” on Tuesday, June 3, 2025
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the intersection of insurance and mobility, announced today that it has been invited to present at the “2025 Virtual Tech …
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the appointment of …
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
GlobeNewswire
·
May 28, 2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
MORRISVILLE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company’s Chief Executive Officer Dr. Roger Jeffs, Chief Financial Officer and Chief Operating Officer Michael Kaseta, and Chief Business …
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
GlobeNewswire
·
May 28, 2025
WEST CHESTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that …
Rackspace Technology Recognized by Dell Technologies with Two Regional Global Alliances Partner of the Year Awards for 2025
GlobeNewswire
·
May 28, 2025
SAN ANTONIO, May 28, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, hybrid multicloud, and AI solutions company, today announced it has been recognized by Dell Technologies with two regional Global Alliances Partner of …
BalkanID Launches BalkanID Lite, Delivering Self-Service Identity and Access Governance to Security Conscious Companies
GlobeNewswire
·
May 28, 2025
AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- BalkanID, a pioneer in AI-driven identity security and access governance, today unveiled its self-service Identity Governance and Administration (IGA) Lite Platform, offering unprecedented flexibility and …
ABLi Therapeutics Strengthens Leadership Team and Board of Directors
GlobeNewswire
·
May 28, 2025
Directors Appointed from Senior Leadership Teams of J…
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and …
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
GlobeNewswire
·
May 28, 2025
Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or …
red violet to Present at the East Coast IDEAS Investor Conference
GlobeNewswire
·
May 28, 2025
BOCA RATON, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the East Coast IDEAS Investor Conference being held June 11-12, 2025 in New …
Snyk Announces First AI Trust Platform to Revolutionize Secure Software Development for the AI Era
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Snyk, the leader in secure AI software development, today launched the Snyk AI Trust Platform, the first AI-native agentic platform specifically built to secure and govern software development in the AI Era. The …
Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates
GlobeNewswire
·
May 28, 2025
JACKSON CENTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and …